Cargando…
The Protective Effects of the Proteasome Inhibitor Bortezomib (Velcade) on Ischemia-Reperfusion Injury in the Rat Retina
PURPOSE: To evaluate the protective effects of bortezomib (Velcade) on ischemia-reperfusion (IR) injury in the rat retina. METHODS: The rats were randomized to receive treatment with saline, low-dose bortezomib (0.05 mg/kg), or high-dose bortezomib (0.2 mg/kg) before the induction of IR injury. Elec...
Autores principales: | Chen, Fang-Ting, Yang, Chung-May, Yang, Chang-Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653862/ https://www.ncbi.nlm.nih.gov/pubmed/23691186 http://dx.doi.org/10.1371/journal.pone.0064262 |
Ejemplares similares
-
Bortezomib (Velcade™) in the Treatment of Multiple Myeloma
por: Field-Smith, Antonia, et al.
Publicado: (2006) -
A case of bortezomib (Velcade)–induced Stevens-Johnson syndrome confirmed by patch test
por: Choi, Gil-Soon, et al.
Publicado: (2021) -
Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3-kinase inhibitor (ZSTK474)
por: LIN, LEHANG, et al.
Publicado: (2013) -
Refractory Splenic Marginal Zone Lymphoma Responsive to Combination Venetoclax and Bortezomib (Velcade) (V(2)) Therapy
por: Roche, Kyle C., et al.
Publicado: (2022) -
The Protective Effects of αB-Crystallin on Ischemia-Reperfusion Injury in the Rat Retina
por: Yan, Huan, et al.
Publicado: (2017)